Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Monthly Performance Review

18 Jun 2015 07:00

RNS Number : 4893Q
BlueCrest AllBlue Fund Ltd
18 June 2015
 



FOR IMMEDIATE RELEASE

 

18 June 2015

 

BLUECREST ALLBLUE FUND LIMITED

MONTHLY PERFORMANCE REVIEW FOR MAY 2015

"Markets were generally calmer in May"

BlueCrest AllBlue Fund Limited (BCAB) rose by 0.7% in May bringing the return for the year to date to 2.0% (Sterling Class NAV). The rolling 12 month return was 5.2% and volatility remained stable at 2.4%.

Markets were generally calmer in May after the volatility of April, although European government bond markets continued to experience very choppy conditions as Bund yields rose and the protracted Greek negotiations dragged on. Economic data in the US and China were generally softer than expected, although European economies continued to expand modestly. There were no meaningful announcements on monetary policy other than the ECB indicated that it may front-load bond purchases ahead of the summer.

 "The return of fixed income volatility proved fruitful"

Six of the seven strategies produced positive returns in May with BlueTrend the only detractor. BlueCrest Capital International once again performed well, up 1.1% for the month, as trading opportunities improved further in fixed income markets. Gains were seen in all regions with the strongest returns coming from the short bias to European rates. The return of volatility to fixed interest markets has once again provided fruitful scope for profits in the fund. With the uncertainties over Greece and a US rate hike combining with thin summer markets, good opportunities remain. AllBlue's allocation to BlueCrest Capital International has been increased further, by 1.5%, for June to 12.7%. An additional increase is likely in the coming months.

By contrast, the allocation to BlueCrest Emerging Markets has been reduced by 2.0% to 7.0%. The fund generated a good performance in May, up 1.5%, with a strong performance across all regions and most strategies, even as the broad emerging markets universe fell. Latin America saw the strongest performance with particularly strong gains from corporate credit and rates in the region. However, BlueCrest are increasingly cautious on emerging markets with distress observed in a number of markets and better opportunities in developed fixed interest.

BlueCrest Equity Strategies saw the balance of the allocation changes for June with an increase of 0.5% to bring its allocation in AllBlue to 14.0%. BlueCrest Equity Strategies also had a strong month in May, up 2.1%, despite generally flat equity markets. Long-short trading generated the best performance with gains around corporate actions and earnings announcements adding to sector-trading gains, most particularly in financials.

A fee change is being implemented on BlueCrest Mercantile Fund whereby the management fee is being reduced from 2% to 1.5% with effect from 1st June. The performance fee remains at 20%.

 "The board is delighted to welcome Sarita Keen as a director"

The board is delighted to welcome Sarita Keen as a director of BCAB with effect from 3rd June. Sarita has over 25 years experience in the fund services industry in Guernsey and we look forward to introducing her to shareholders in the coming months.

The BCAB share price has been relatively stable to NAV during the month with regular investor buying seen around the 5% discount level. As a result the buyback programme operated infrequently during the month. On 11th June the Company was notified that BlueCrest related entities now hold over 5% of shares in the Company.

 

Disclaimer:

This document is directed only at: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005; or (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and persons who receive this document who do not fall within (i) or (ii) above should not rely on or act upon this document.

 

This document is issued by BlueCrest AllBlue Fund Limited (the "Company") to and for the information of its existing shareholders and does not in any jurisdiction constitute investment advice or an invitation to invest in the shares or any other securities of the Company or any other entity (body corporate or otherwise).

 

The Company has used reasonable care to ensure that the information included in this document is accurate at the date of its issue, but does not undertake to update or revise the information, including any information relating to AllBlue Limited and its underlying funds (the "Funds") provided by BlueCrest Capital Management (UK) LLP or any member of the BlueCrest group of companies (as applicable) ("BlueCrest"), or guarantee the accuracy of such information. To the extent permitted by law neither the Company, the Funds, BlueCrest nor their directors or officers shall be liable for any loss or damage that anyone may suffer in reliance on such information.

 

The information in this document may be changed by the Company at any time. Past performance cannot be relied on as a guide to future performance. The Company's investment strategy is speculative and entails substantial risks. The value of an investment may go down as well as up and some or all of the total amount invested may be lost. This document may not, in whole or in part, directly or indirectly, be taken, transmitted or distributed into the United States of America, its territories or possessions or made available to any national, resident or citizen of the United States of America or any other jurisdiction where applicable laws prohibit its release, distribution or publication. Any failure to comply with these restrictions may be a violation of the law in relevant jurisdictions.

 

JTC (Guernsey) Limited

Secretary

 

Tel: Guernsey 01481 702400

 

END OF ANNOUNCEMENT

E&OE - in transmission

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQDLFFEQFLBBF
Date   Source Headline
6th Jun 20193:29 pmRNSNet Asset Value(s)
5th Jun 20194:54 pmRNSTransaction in Own Shares
4th Jun 20195:14 pmRNSTransaction in Own Shares
29th May 20195:06 pmRNSChange of Company Secretary and Registered Office
29th May 20194:59 pmRNSTransaction in Own Shares
29th May 20191:41 pmRNSNet Asset Value(s)
24th May 20195:13 pmRNSTransaction in Own Shares
22nd May 20195:00 pmRNSTransaction in Own Shares
22nd May 20191:34 pmRNSNet Asset Value(s)
21st May 20195:11 pmRNSTransaction in Own Shares
21st May 20194:59 pmRNSHolding(s) in Company
21st May 20191:47 pmRNSNet Asset Value(s)
16th May 20195:35 pmRNSTransaction in Own Shares
14th May 20195:28 pmRNSTransaction in Own Shares
14th May 20191:10 pmRNSNet Asset Value(s)
3rd May 201911:47 amRNSNet Asset Value(s)
30th Apr 201912:04 pmRNSNet Asset Value(s)
24th Apr 201912:50 pmRNSNet Asset Value(s)
23rd Apr 20191:34 pmRNSNet Asset Value(s)
16th Apr 201912:41 pmRNSNet Asset Value(s)
16th Apr 20197:00 amRNSAnnual Financial Report
5th Apr 20194:29 pmRNSHolding(s) in Company
3rd Apr 20191:05 pmRNSNet Asset Value(s)
2nd Apr 20191:50 pmRNSHolding(s) in Company
26th Mar 201912:16 pmRNSNet Asset Value(s)
26th Mar 20199:42 amRNSStatement re : Liquidation of AllBlue Funds
25th Mar 20195:23 pmRNSTransaction in Own Shares
22nd Mar 201912:46 pmRNSNet Asset Value(s)
21st Mar 20199:24 amRNSHolding(s) in Company
19th Mar 20191:25 pmRNSNet Asset Value(s)
12th Mar 20195:23 pmRNSTransaction in Own Shares
12th Mar 201911:36 amRNSNet Asset Value(s)
11th Mar 201912:25 pmRNSHolding(s) in Company
8th Mar 20195:07 pmRNSTransaction in Own Shares
5th Mar 20191:18 pmRNSNet Asset Value(s)
27th Feb 201912:47 pmRNSNet Asset Value(s)
26th Feb 201910:46 amRNSNet Asset Value(s)
22nd Feb 201910:19 amRNSHolding(s) in Company
20th Feb 20199:41 amRNSNet Asset Value(s)
15th Feb 20194:52 pmRNSStatement re Membership of Audit Committee
12th Feb 201911:13 amRNSNet Asset Value(s)
5th Feb 201912:13 pmRNSNet Asset Value(s)
4th Feb 20195:27 pmRNSTransaction in Own Shares
30th Jan 201911:24 amRNSNet Asset Value(s)
29th Jan 201911:20 amRNSNet Asset Value(s)
23rd Jan 201911:39 amRNSNet Asset Value(s)
16th Jan 201912:26 pmRNSNet Asset Value(s)
10th Jan 20195:18 pmRNSTransaction in Own Shares
9th Jan 20195:29 pmRNSTransaction in Own Shares
8th Jan 20195:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.